Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
01/02/2008 | CN101095948A Use of ulinastain in the preparing of treating and/or preventing sudden arrest of heart beat tritocerebrum damnification medicine |
01/02/2008 | CN101095899A Chinese herb medicine for treating coronary heart disease |
01/02/2008 | CN101095898A Medicine for treating hypertension |
01/02/2008 | CN101095894A Chinese traditional medicine composition for treating myocardium disease and method of making the same |
01/02/2008 | CN101095885A Chinese traditional medicine for treating myocarditis |
01/02/2008 | CN101095851A Chinese traditional medicine soup composition and method of making the same |
01/02/2008 | CN101095845A Century health preserving magical wine |
01/02/2008 | CN101095823A Heart disease treating medicine |
01/02/2008 | CN101095813A Liposoluble effective extracts from onion white and the extracting method thereof |
01/02/2008 | CN101095812A Polarity effective extracts from onion white and the extracting method thereof |
01/02/2008 | CN101095805A Medicine made by onion and aloe and method for preparing the same |
01/02/2008 | CN101095768A Chinese traditional medicine capsule for treating primary hypertension for persons in middle and old age |
01/02/2008 | CN101095755A Patch for treating hypertension |
01/02/2008 | CN101095737A Medicine for treating arteriosclerosis hypertension and method for preparing the same |
01/02/2008 | CN101095728A Medicament for treating thromboangitis obliterans and method for producing the same |
01/02/2008 | CN101095727A Hemorrhoid medicine for hui people and vegetarian people |
01/02/2008 | CN101095724A Technics for extracting lotus leaf flavone |
01/02/2008 | CN101095723A Chinese traditional medicine composition for treating ischemic stroke and method for preparing the same |
01/02/2008 | CN101095715A Cardiac and cerebral vascular disease treating medicine composition |
01/02/2008 | CN101095703A Process for preparation of ganoderma lucidum propolis |
01/02/2008 | CN101095702A Graininess medicine containing hirsutella.hepia - cordycepsíífungusíípowder and method for preparing the same |
01/02/2008 | CN101095701A Flaky medicine containing hirsutella.hepia - cordycepsíífungusíípowder and method for preparing the same |
01/02/2008 | CN101095698A Probiotics and prebiotics for preventing and treating foetid faeces and foetid faeces poisoning syndrome and the composition preparations thereof |
01/02/2008 | CN101095697A Extractive of bdella and/or lumbricus with the molecular weight below 5800 dalton |
01/02/2008 | CN101095683A Chinese traditional medicine for treating hypertension and method for making same |
01/02/2008 | CN101095682A Oral preparations of ivabradine or the medical salt thereof |
01/02/2008 | CN101095680A Preparations containing rosuvastatin calcium and amlodipine and method for preparing the same |
01/02/2008 | CN101095676A Application of sophocarpine and the medicine salt thereof in the preparing of the medicine for treating arrhythmia |
01/02/2008 | CN101095673A Application of 3-benzyl-5-(2-nitrophenoxymethyl)-gamma-butyrolactone as the cytoplasm vacuolated medicine generated by restraining chloro-quinine inducement |
01/02/2008 | CN101095669A Osthole phospholipid complexes and method for preparing the same and application thereof |
01/02/2008 | CN101095663A Nicergoline sustained-release capsules and method for preparing the same |
01/02/2008 | CN101095661A Isosorbide mononitrate orally disintegrating tablets |
01/02/2008 | CN100358899C Platelet activation factor resisting compound |
01/02/2008 | CN100358892C 7-oxo pyridopyrimidines |
01/02/2008 | CN100358891C Pyranones useful as ATM inhibitors |
01/02/2008 | CN100358890C 喹唑啉衍生物类激酶抑制剂 Quinazoline derivatives kinase inhibitors |
01/02/2008 | CN100358888C Novel guanidine mimics as factor Xa inhibitors |
01/02/2008 | CN100358878C Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof |
01/02/2008 | CN100358874C 3,4-dihydroquinazoline derivatives as t-type calcium channel blockers and method of preparing the same |
01/02/2008 | CN100358869C Carbamate caspase inhibitors and uses thereof |
01/02/2008 | CN100358867C Heterocyclic inhibitors of glycogen synthase kinase GSK-3 |
01/02/2008 | CN100358865C Sulfonamide phenylalkylamine compound, its preparation method and application |
01/02/2008 | CN100358595C Safety shield system for prefilled syringe |
01/02/2008 | CN100358584C Novel compositions magnetic particles covered with gem-bisphosphonate derivatives |
01/02/2008 | CN100358578C Composition for cooperative therapy and method thereof |
01/02/2008 | CN100358577C Treatment of auto immune diseases with antagonists which bind to B cell surface markers |
01/02/2008 | CN100358558C Formulation for treating cardiovascular and cerebrovascular disease and its preparation process and quality control method |
01/02/2008 | CN100358550C Chinese traditional medicine for treating bradycardia |
01/02/2008 | CN100358545C Freeze drying powder and injection preparation in use for invigorating pulse-beat, and preparation method |
01/02/2008 | CN100358542C Medicine capable of reducing blood fat and treating anaphylactic rhinitis and preparation method thereof |
01/02/2008 | CN100358539C Quality control method for ginkgo-dipyridamine injection |
01/02/2008 | CN100358530C Medicine prepn for treating cerebral apoplexy and its prepn |
01/02/2008 | CN100358520C Edalavon powder for ampoul injection having good stability and its preparation method |
01/02/2008 | CN100358515C Treatment of neurodegenerative and cardiovascular disorders |
01/02/2008 | CN100358506C Compound musk drip pill and its preparation method |
01/02/2008 | CN100358500C Fleabane and earthworm dripping pill and its preparing method |
01/02/2008 | CN100358495C Prepared licorice granule and its preparation method |
01/02/2008 | CN100358494C Inhalation system |
01/01/2008 | US7314940 For therapy and prophylaxis of neurodegenerative disorders related to apoptosis and/or inflammation |
01/01/2008 | US7314936 antiinflammatory agents; 1H-imidazo[4,5-b]pyridin-7-indole-2-yl- derivatives; autoimmune and proliferative disorders; inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction; rheumatoid arthritis, ulcerative colitis/Crohn's disease, central nervous system diseases |
01/01/2008 | US7314934 Substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds, e.g., 8-(2,6-Difluoro-phenyl)-4-(4-fluoro-2-methyl-phenyl)-2-(2-hydroxy-1-hydroxymethyl-ethylamino)-8H-pyrido[2,3-d]pyrimidin-7-one; CSBP/p38 kinase inhibitors |
01/01/2008 | US7314889 Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
01/01/2008 | US7314881 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds |
01/01/2008 | US7314876 Administering to mammals nitrogen compounds, as mitogen activated kinase inhibitors, for prophylaxis asthma, respiratory system disorders, graft versus host disease, atherosclerosis and arthritis |
01/01/2008 | US7314873 (Halo-benzo carbonyl)heterobi cyclic p38 linase inhibiting agents |
01/01/2008 | US7314871 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors, for treatment of hypertension |
01/01/2008 | US7314870 Compounds, their preparation and use |
01/01/2008 | US7314867 Pharmaceutical composition comprising a retro-iverso isomer peptide |
01/01/2008 | US7314742 Immunoassay diagnosis of susceptibility to atherosclerosis by analyzing blood for presence of enzyme using polyclonal or monoclonal antibodies; elevated levels are indicative of susceptibility |
01/01/2008 | US7314728 Methods of treating peripheral arterial occlusions |
01/01/2008 | US7314625 Generating polyclonal antisera that reduce adherence of the microorganism expressing the Type IV pilin loop sequence to the epithelial cells |
01/01/2008 | US7314617 Platelet rich plasma, no exogenous activator; sodium bicarbonate buffer, citrate dextrose anticoagulant |
01/01/2008 | US7314484 Methods and devices for treating aneurysms |
12/27/2007 | WO2007149874A1 Imidazolidinone kv1.5 potassium channel inhibitors |
12/27/2007 | WO2007149568A2 N- (4-chl0r0-3-methyl-5-is0xaz0lyl) -2- [2-methyl-4, 5- (methylenedioxy) phenylacetyl] -thiophene-3-sulfonamide |
12/27/2007 | WO2007149451A2 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
12/27/2007 | WO2007149366A1 Prolonged improvement of renal function comprising infrequent administration of an aa1ra |
12/27/2007 | WO2007149031A1 Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases |
12/27/2007 | WO2007148775A1 Chain amine compound |
12/27/2007 | WO2007148774A1 Cyclic amine compound |
12/27/2007 | WO2007148714A1 Implant using rifamycin derivative |
12/27/2007 | WO2007148713A1 Drug for treating vascular disease or drug for controlling cell proliferation comprising rifamycin derivative as the active ingredient |
12/27/2007 | WO2007148711A1 N-(3,4-disubstituted phenyl)salicylamide derivative |
12/27/2007 | WO2007148697A1 Inhibitor of expression of nuclear transcription factor ap-1, and pharmaceutical product and product using the inhibitor |
12/27/2007 | WO2007148494A1 Agent for increasing testosterone level |
12/27/2007 | WO2007147889A2 Preparation of telmisartan salts |
12/27/2007 | WO2007147824A1 Cinnamoyl-piperazine derivatives and their use as par- i antagonists |
12/27/2007 | WO2007147822A1 Phenylpentadienoyl derivatives and their use as par 1 antagonists |
12/27/2007 | WO2007147713A1 Amino derivatives of b-homoandrostanes and b-heteroandrostanes |
12/27/2007 | WO2007147330A1 The application of the bakuchiol compounds |
12/27/2007 | WO2007125315A3 Pharmaceutical compounds |
12/27/2007 | WO2007124254A3 Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
12/27/2007 | WO2007117559A8 Renin inhibitors |
12/27/2007 | WO2007106708A3 Combinations of the angiotensin ii antagonist valsartan and the nep inhibitor daglutril |
12/27/2007 | WO2007106494A3 Methods and compositions for treatment of diastolic heart failure |
12/27/2007 | WO2006016383A3 Natural composition |
12/27/2007 | WO2003066824A3 Albumin-fused kunitz domain peptides |
12/27/2007 | US20070299139 Lyophilisate Comprising N-Diaminomethylene-2-Methyl-4,5-Di(Methylsulfonyl)Benzamide |
12/27/2007 | US20070299138 Treating tumors by administering the octasodium salt of the tetrameric cyclic compound of 4,5-dihydroxynaphthalene-2,7, disulfonic acid linked by methylene bridges; inhibits the secretion of matrix metalloproteinase by endothelial cells |
12/27/2007 | US20070299136 Crystalline and Amorphous Forms of Efaproxiral Sodium |